Affecting more than 100,000 American children and adults, sickle cell disease is an inherited hemoglobinopathy that results when a single-nucleotide mutation in the ß-globin gene yields an abnormal “sickle” hemoglobin (HbS). Now, these patients may be eligible for a one-time gene therapy that offers the potential of a durable functional cure by eliminating severe VOCs and associated hospitalizations.
Touted as a more natural approach to hormone replacement therapy, this plant-based anti-aging remedy has evolved from an unregulated safety concern to a mainstay of modern medicine.
Menopause is a normal, natural event in every woman’s life, but it can cause a variety of uncomfortable symptoms. New therapies show promise for bringing relief and an improved quality of life.
For patients with genetic disease, recent evolution of and FDA approval for gene therapies are transforming care and turning an ambitious dream into a life-changing reality. But getting affordable treatments to patients safely and efficiently remains a challenge.
The future of healthcare is being driven by digital transformations and emerging technology that provide preventive, personalized and predictive medicine.
The CDC's National Institute for Occupational Safety and Health (NIOSH) released a guide for hospital leaders to improve healthcare worker wellbeing.
The Departments of Health and Human Services, Labor and the Treasury have released the Short-Term, Limited- Duration Insurance and Independent, Noncoordinated Excepted Benefits Coverage, or “Junk Insurance,” final rules. Short-term, limited-duration insurance (STLDI) is a type of health insurance that is typically designed to fill temporary gaps in coverage when an individual is transitioning from one source of coverage to another.
The U.S. Department of Health and Human Services (HHS) has released a white paper highlighting steps the organization has taken to prevent and mitigate drug shortages and proposing additional solutions for policymakers to consider.
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare and Medicaid Services (CMS), is finalizing policies to ensure Medicare Advantage and Medicare Part D prescription drug plans best meet the needs of people with Medicare.
Three top vaccine producers are making newer vaccines that not only protect against the newer sublineages of COVID-19, but that also protect against other respiratory viruses.
Although history has proven the success of vaccines in controlling the spread of diseases, emerging threats are concerning. However, hope is on the horizon with studies of newer vaccines.
Inborn errors of immunity (IEI) increase morbidity and mortality risks, particularly from respiratory tract infections. Hence, vaccination becomes pivotal for IEI patients.
